What Causes Scleroderma? Unraveling the Mystery Behind the Disease
Published: Sep 27, 2024
Systemic sclerosis, or scleroderma, is a complex disease that causes hardening of the skin and sometimes affects internal organs. Understanding what causes this condition can help in managing its symptoms and complications.
Contents
What is Systemic Sclerosis?
Systemic sclerosis (SSc), commonly known as scleroderma, is a condition characterized by the thickening and hardening of the skin due to increased collagen deposits. It is a rare autoimmune disease that can also affect internal organs, leading to complications such as lung, heart, and kidney problems. The disease is categorized into two main types: localized and systemic, with systemic forms being more severe due to organ involvement.
The Enigma of Its Causes
The exact cause of scleroderma remains unknown, making it a challenging condition to treat. Researchers believe it involves a combination of genetic, environmental, and immune system factors. The disease may be triggered by an abnormal immune response, leading to excessive collagen production and tissue scarring. Although it is not hereditary, certain genetic markers may increase the risk of developing scleroderma.

Risk Factors and Triggers
Several factors may increase the likelihood of developing scleroderma, including exposure to certain chemicals or infections. Women are more commonly affected than men, and symptoms often appear between the ages of 30 and 50. While the precise triggers are still being studied, lifestyle and environmental factors are thought to play a role in disease onset and progression.
Frequently Asked Questions
Scleroderma is a disease that causes skin thickening and can affect internal organs.
It's difficult to treat because its exact cause is unknown.
Women aged 30-50 are most at risk.
No, but certain genetic markers may increase risk.
Key Takeaways
While the causes of scleroderma are still unclear, understanding risk factors can help in managing the disease.
Get started on learning more about scleroderma by discussing with Doctronic.Related Articles
References
Denton CP, Hughes M, Gak N, et al. BSR and BHPR guideline for the treatment of systemic sclerosis. Rheumatology (Oxford) 2016; 55:1906.
Kowal-Bielecka O, Fransen J, Avouac J, et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis 2017; 76:1327.
Always discuss health information with your healthcare provider.